1Cross WL, Csernok E, Helmchen U. Antineutrophil cytoplasmic autoantibodies, autoantigen, and systemic vasculitis. APMIS, 1995, 103: 81.
2Gross WL, Hauschild S, Mistry N. The clinical relevance of ANCA in vasculitis. Clin Exp lmmunol, 1993, 93 (Suppl. 1): 32.
3Scott MG, Briles DE, Nahm MH. Selective IgG subclass expression: biological clinical and functional aspects. In: Shakib F, ed. The Humann IgG Subclasses: Molecular Analysis of Structure Function and Regulation Pergamon Press. Oxford, 1990, 161-179.
4Charles A, Janeway Jr, Travers P. Immuno Biology. 2^th ed Current Biology Lid/Garbard publishing Inc. 1988, 3:2-5.
6Schur PH. IgG subclasses-a revies. Ann Allergy, 1987, 58: 89.
7Segelmark M, Butkowski R, Wieslander J. Antigen restriction and IgG subclasses among anti-GBM autoantibodics. Nephrol Dial Transplant,1990, 5: 991-996.
8Falk RJ, Terrell RS, Charles LA, et al. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicalsin vitro. Pro Natl Acad Sci USA, 1990, 87: 4115-4119.
9Mulder AH, Stegeman CA, Kallengerg CG. Activation of granulocytes by anti-neutrophil cytoplasmic antibodies (ANCA) in Wegener's granulomatosis: a predominant role for the IgG3 subclass of ANCA. Clin Exp Innunol,1995, 101(2): 227-232.
10Kimberly RP. Fc receptors and neutrophil activation. Blackwell Science Ltd, Clinical and Experimental Immunology, 2000, 120(Suppl 1): 1-79.
9L. Harper, C.O. Savage. ANCA-associated renal vasculitis at the end of the twentieth century-a disease of older patients [ J ]. Rheumatology,2005,44: 495 - 501.
10Y Wang Y,MH Zhao,J Yu,et al. The clinical and pathological characteristics of Chinese elderly patients with anti-neutophil cytoplasmic autoantibodis associatd small vesl vasculitis [ J 1. Experimental Gerontology,2004,39 : 1401 - 1405.
